Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.24.1.u1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Accumulated amortization of deferred leasing costs $ 41,846 $ 41,448
Common shares of beneficial interest, par value (in dollars per share) $ 0.01 $ 0.01
Common shares of beneficial interest, shares authorized (in shares) 150,000,000 150,000,000
Common shares of beneficial interest, shares issued (in shares) 112,640,861 112,555,352
Common shares of beneficial interest, shares outstanding (in shares) 112,640,861 112,555,352
Investing Receivables    
Investing receivable allowance for credit loss $ 2,361 $ 2,377